This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the fast-evolving pharmaceutical industry, Vertex Pharmaceuticals stands out not only for its scientific breakthroughs but also for its human-centric approach to digital transformation. The digitization of supplychain operations has become a competitive advantage for Vertex.
Supplychains, which facilitate the movement of products from manufacturers to consumers, have historically encountered issues such as inefficiency, fraud, and a lack of transparency. This will enable diamond jewelry consumers at scale to engage with the unique journeys their diamonds have taken from source.
The global manufacturing and distribution of pharmaceuticals and the regulatory requirements of countries have always made pharmaceuticalsupplychains a challenge. Read more Five Technological Advances that Will Transform PharmaceuticalSupplyChain Visibility.
How Global SupplyChains, Strategic Rivals, and Quality Breakdowns Threaten U.S. manufacturing, addressing supplychain dependencies on China, and enhancing national security through biotechnology leadership. pharmaceuticalsupplychain vulnerabilities.
by Bill DuBois I recently attended the LogiPharma conference in Princeton, NJ to hear a number of speakers give their thoughts on the state of the pharmaceuticalsupplychain. He talked about the 5 C’s for a CMO relationship in pharma. For the pharma CMO relationship it was worth calling out compliance.
How should a global manufacturer make a decision? And how can supplychain planning help? In one project, I am interviewing over fifty supplychain leaders on their perceived impact of advanced planning, what makes a good plan, and how effectively they use the technology. What defines a feasible plan?
If you’re a pharmaceutical company, you fear the hit to your business, both headlines and bottom line. Makers of weight loss drugs are looking out a big picture window of patented opportunity right now, but this rosy view is blocked by supplychain challenges. What role can supplychain play in preventing stockouts?
Wikipedia Unleashing the Contrarian Here are my thoughts this morning over coffee: Gartner Top 25: Really A Celebration of SupplyChain Leadership? Designed to lift the profession and celebrate supplychain results, I struggle to find that the methodology supports either objective. I don’t think so.
Medical and pharmaceuticalmanufacturers have faced increasing logistical challenges over the past two years. Amid significant regulatory and compliance changes around the world, they've had to contend with massive supplychain disruptions caused by the pandemic.
Executing lean concepts in Pharma, Biopharma and Medical Devices is critical to maintain and improve efficiency, quality, regulatory compliance and productivity. Life sciences manufactures today are impacted by several trends, particularly in areas such as personalization and increasing product portfolio complexity.
Kearney research shows that the more companies invest, the bigger the average ROI Investments in supplychain firms and technologies represent 15-20% of total venture capital investments, according to a recent report by the management consulting firm Kearney. More than 150 supplychain startups have been acquired in the last two years.
In early April I attended the LogiPharma Europe 2018 conference in Montreux, Switzerland, an event that attracted more than 800 attendees, including practitioners and executives from pharma and medical device industries, along with software vendors and many service providers. Patient-centric networks are reshaping pharmasupplychains.
The Digital Age of Manufacturing gives pharmaceutical executives new abilities. Improving cost performance while maintaining quality and compliance in the midst of rapidly changing supplychain models among internal and external manufacturing takes both careful thought and a lot of hard work.
The Covid-19 pandemic severely exacerbated the shock to the Global economy.Global and Regional Trade and related Supplychains experienced unprecedented disruptions. The pandemic exposed major supplychain vulnerabilities affecting the Manufacturing, Industrial Logistics , Commercial sectors as well as Food Security challenges.
Supplychain resiliency and sustainability are top priorities for CEOs today. To achieve these goals, corporate leadership must focus on two key areas: shift from internally focused supplychains to collaborative supply networks and actively design their supplychains.
According to one survey , only 27% of leaders believe that they have the talent needed to meet current supplychain performance requirements. What should supplychain leaders be looking for to close the talent gap? AGCO Logistics Team Accepts Prestigious SupplyChain Award.
Pharmacies typically have a vast supplychain network. Pharmaceutical Inventory software is valuable for pharmaceuticals. In this article, we will discuss what makes inventory management software an essential tool for pharmaceutical businesses. Managing inventory effectively and carefully is necessary for pharmacy.
As I was enjoying the holidays, I had an opportunity to reflect on the year past and what the future holds for supplychains. However, organizations will need to be deliberate in designing supplychains with optionality so it does not become cost prohibitive. SupplyChain Design is essential in tackling these.
Josh Allen and Joe Lynch discuss Tive’s validated, real-time visibility for pharma. Josh is CRO at Tive , a leading provider of real-time supplychain visibility insights that help logistics professionals actively manage their in-transit shipments’ location and condition. About Josh Allen . About Tive.
Vaccinating the SupplyChain with Andrew Kelley. Andrew Kelley and Joe Lynch discuss vaccinating the supplychain. Andrew is the Chief Commercial Officer at BoxLock , a company that facilitates secure vaccine transfer for biotechs, manufacturers, labs, hospitals, and clinics. About Andrew Kelley.
The cloud has emerged as the cornerstone of modern business and supplychain innovation. From retail and food and beverage to manufacturing and life sciences, companies from a wide variety of industries are realizing the benefits of the technology, revolutionizing how they operate, collaborate, and generate value.
This is a story for the Eds, Franks, and Toms working together in supplychains across the globe. It is also a story for a young supplychain manager attempting to make a difference, but feeling stymied. Frank, the line manager for manufacturing, dominated the meetings. Need for SupplyChain Leadership.
Supplychain sustainability is a higher priority than ever. In MIT’s State of SupplyChain Sustainability 2021 , 80% of executives surveyed said the pandemic either had no impact on their commitment or increased it. We must plan, source, make, and deliver differently for supplychain sustainability.
Earlier this week, I attended the LogiPharma conference, a wonderful event for supplychain professionals working in the pharmaceutical industry. All-in-all, it was a great validation of my point of view about where the pharma industry is with regards to its supplychain challenges, maturity and where it needs to go.
Today, we published The SupplyChains to Admire for 2023. Nvidia, Northrup Grumman, PACCAR Inc, PCA (Packaging Corporation of America), ResMed, Rockwell Automation, Ross Stores, Taiwan Semiconductor Manufacturing (TSMC) Company, Tempur-Pedic, TJX, Toro, Toyota, West Pharma, United Tractors, and Urban Outfitters.
Factories for most commodities (other than essential commodities, pharma, medicinal and medical devices, food and groceries) were shutdown globally. China fully shutdown its manufacturing output during this phase affecting consumers globally. Huge demand supply issues breaking the ever-so-fragile supplychain globally.
Much has been written about what it takes to run a successful supplychain in the era of “get it to me fast and get it to me cheap.” Supplychain professionals are looking for ways to store goods closer to customers by investing in micro fulfillment centers and to optimize their facilities so orders can be processed faster.
This week, Gartner is hosting their annual supplychain conference. It is now the Gartner SupplyChain Top 25. The research tries to establish “ who did supplychain best ” by looking at a weighted formula of Year-over-Year Growth, Return on Assets (ROA), and Inventory Turns for the Fortune 500 companies.
While Contract Pharma & BioPharma manufacturers continue to experience an increase in demand for more projects, new challenges are emerging from nearly every angle including new regulatory and quality requirements, workforce shortages and of course, supplychain disruptions. is likely to reach 2.1
Megatrends Shaping SupplyChain Innovation. While the COVID-19 pandemic woke up supplychains around the world, the ripple effects continue to disrupt in both size and scope. How are supplychains planning for further disruption and uncertainty? Creating a more resilient supplychain.
Manufacturing is on the cusp of an explosion in growth and innovation in 2018. Regulatory reform has been top-of-mind for supplychain executives and political leaders in the US since the 2016 election. These facts set the stage for exponential manufacturing growth in 2018. Check Out the Top 2018 Manufacturing Trends.
states, obvious disruptions to supplychains and supplychain risk management were a given. Many of the states affected contained key ports and supply destinations, as well as transportation and logistics hubs. The human links of the supplychain were stressed. These ports accounted for 18.3%
The future of supplychain I foresee brings new risks and challenges, along with recognition that doing things the same way will no longer lead to the same success. Just as the saguaro is both nursed by and supports life in its ecosystem, it behooves supplychains to invest in their ecosystems, both suppliers and employees.
The global supplychain that we know today is built on three assumptions: rational government policy, low variability, and availability of logistics. The impact varies by supplychain sector and value chain. We have heard that there is a focus on near-shoring, reshoring, and local manufacturing. What to do?
Can You Prevent SupplyChain Disruptions in Life Sciences? Supplychain disruptions in the life sciences industry can have serious consequences. While its impossible to eliminate all risks, companies and the industry at large can take proactive steps to minimize disruptions and improve supplychain resilience.
5 Megatrends Shaping SupplyChain Innovations. In these times of global turmoil, there are five (5) important megatrends shaping supplychain innovations in the coming years, namely in e-fulfillment, sourcing, food and agriculture, labour intensive operations, and halal supplychain management.
Coronavirus continues to impact the world, stunting supplychains and the global economy. Steve Banker has also recently highlighted 20 things to keep in mind as we make contingency plans for the impact […].
Subscribe to SupplyChain Game Changer. How Cold Chain Differs Between the Food and Pharmaceutical Industries! An increased level of competition characterizes the pharmaceutical market. Today, software development is an effective marketing tool in the pharmaceutical market. Email Address.
The post What other industries can learn from pharmaceuticalmanufacturing appeared first on IT SupplyChain. By Alexandra Hughes (pictured). Industry Sales Manager, COPA-DATA UK.
The post What other industries can learn from pharmaceuticalmanufacturing appeared first on IT SupplyChain. By Alexandra Hughes (pictured). Industry Sales Manager, COPA-DATA UK.
How MES is Shaping the Future of Manufacturing and Boosting Production Efficiency What is a Manufacturing Execution System (MES)? A manufacturing execution system (MES) is a comprehensive, dynamic software system that monitors, tracks, documents, and controls the process of manufacturing goodsfrom raw materials to finished products.
From early on in the Covid-19 pandemic , and for pretty obvious reasons , procurement in healthcare and pharmaceuticals has been in the spotlight like never before. Managing supplier s in a highly volatile economic, societal and environmental situation was especially challenging for the pharma industry.
Over the years, cost and efficiency ruled the supplychain agenda. The Chief SupplyChain Officer (CSCO) has gained prominence as organizations tackle the disruption and prepare for a post-COVID world. Beyond the pandemic, there are fundamental shifts in businesses that make such alignment an imperative.
We organize all of the trending information in your field so you don't have to. Join 102,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content